Following Win Over Boston Scientific, Medinol Seeks Taxus Liberté Royalties

Medinol says it will pursue royalties from sales of Boston Scientific's Taxus Liberté drug-eluting stent following a Sept. 21 settlement of the firms' long-running patent infringement suit